Brickell Stock Analysis

BBIDelisted Stock  USD 1.79  0.34  23.45%   
The current indifference towards the small price fluctuations of Brickell Biotech could raise concerns from stockholders as the firm is trading at a share price of 1.79 on very low momentum in volume. The company executives did not add any value to Brickell Biotech investors in December. However, most investors can still diversify their portfolios with Brickell Biotech to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.71. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Brickell Biotech partners.
Continue to Trending Equities.
  
The Brickell Biotech stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Brickell Biotech is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Brickell Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Brickell Biotech's ongoing operational relationships across important fundamental and technical indicators.

Brickell Stock Analysis Notes

About 13.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Brickell Biotech recorded a loss per share of 0.42. The entity last dividend was issued on the 3rd of September 2019. The firm had 1:45 split on the 5th of July 2022. Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people. For more info on Brickell Biotech please contact Garth Braun at 720 505-4755 or go to www.ir.brickellbio.com.

Brickell Biotech Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Brickell Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Brickell Biotech or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Brickell Biotech is now traded under the symbol FRTX. Please update your portfolios or report it if you believe this is an error. Report It!

Brickell Biotech Upcoming and Recent Events

Earnings reports are used by Brickell Biotech to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Brickell Biotech previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report8th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End8th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Brickell Biotech SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Brickell Biotech prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Brickell Biotech investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Brickell Biotech specific information freely available to individual and institutional investors to make a timely investment decision.
1st of September 2022
Financial Statements and Exhibits. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
View
23rd of August 2022
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
11th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
29th of July 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
20th of July 2022
Financial Statements and Exhibits. Other Events
View
5th of July 2022
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
View
15th of June 2022
Financial Statements and Exhibits. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
7th of June 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View

Brickell Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 6.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brickell Biotech's market, we take the total number of its shares issued and multiply it by Brickell Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Brickell Profitablity

Brickell Biotech's profitability indicators refer to fundamental financial ratios that showcase Brickell Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, Brickell Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Brickell Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Brickell Biotech's profitability requires more research than a typical breakdown of Brickell Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Investment(31.48) (33.96) 
Return on Average Assets(22.02) (23.76) 
Return on Average Equity(26.04) (28.10) 
Return on Invested Capital 17.75  19.15 
Return on Sales(87.78) (90.09) 

Brickell Biotech Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Brickell Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Brickell Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Brickell Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Brickell Biotech Technical and Predictive Indicators

About Brickell Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Brickell Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brickell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Brickell Biotech. By using and applying Brickell Stock analysis, traders can create a robust methodology for identifying Brickell entry and exit points for their positions.
Last ReportedProjected for 2023
Operating Margin(111.40) (120.19) 
EBITDA Margin(102.86) (110.98) 
Gross Margin 10.32  14.48 
Profit Margin(107.85) (116.36) 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Brickell Biotech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module
Continue to Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Tools for Brickell Stock

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEO Directory
Screen CEOs from public companies around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years